FTC sues drug middlemen for allegedly inflating insulin prices
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
Pesky medical bill? Most people don't take a key step to manage that debt, study finds
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
ArogyaJivan: Revolutionizing Global Healthcare Access with Transparency and Excellence
23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
Healthy Returns: How competitive can Roche be in the weight loss drug market?
FDA clears Apple's sleep apnea detection feature for use. Here's how it works
